Chemfab Alkalis Limited
Chemfab Alkalis Limited (CHEMFAB) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Commodities›Chemicals›Chemicals & Petrochemicals›Commodity Chemicals
chemfabalkalis.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-03
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023BSE balance sheet (this exchange's own filing had none for this period) | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 80 Cr | 86 Cr | 82 Cr | 77 Cr | 82 Cr | 84 Cr | 92 Cr | 92 Cr | 77 Cr | 68 Cr | 75 Cr | 73 Cr |
| Operating expenses (approx.) | 69 Cr | 71 Cr | 70 Cr | 68 Cr | 72 Cr | 72 Cr | 79 Cr | 80 Cr | 71 Cr | 66 Cr | 66 Cr | 63 Cr |
| EBITDA | 11 Cr | 15 Cr | 12 Cr | 8 Cr | 10 Cr | 12 Cr | 13 Cr | 11 Cr | 5 Cr | 2 Cr | 9 Cr | 10 Cr |
| OPM % | 13.7% | 17.6% | 15.0% | 10.9% | 12.4% | 14.2% | 14.4% | 12.3% | 7.1% | 2.8% | 11.4% | 13.8% |
| Other income | 1 Cr | 2 Cr | 2 Cr | 3 Cr | 0.60 Cr | 3 Cr | 1 Cr | 1 Cr | 2 Cr | 3 Cr | 3 Cr | 2 Cr |
| Interest | 0.06 Cr | 0.43 Cr | 0.41 Cr | 0.94 Cr | 1 Cr | 1 Cr | 2 Cr | 2 Cr | 2 Cr | 2 Cr | 2 Cr | 2 Cr |
| Depreciation | 6 Cr | 5 Cr | 6 Cr | 7 Cr | 9 Cr | 10 Cr | 11 Cr | 6 Cr | 7 Cr | 7 Cr | 8 Cr | 8 Cr |
| Profit before tax | 7 Cr | 11 Cr | 8 Cr | 3 Cr | 0.73 Cr | 4 Cr | -7 Cr | 5 Cr | -1 Cr | -5 Cr | 1 Cr | 2 Cr |
| Tax % | 35.4% | 34.4% | 32.1% | 66.5% | 173.5% | 48.2% | -25.0% | 45.8% | -51.0% | 7.2% | 60.4% | -157.7% |
| Net profit | 4 Cr | 7 Cr | 5 Cr | 0.90 Cr | -0.53 Cr | 2 Cr | -9 Cr | 3 Cr | -2 Cr | -4 Cr | 0.48 Cr | 6 Cr |
| EPS (₹) | ₹3.03 | ₹5.00 | ₹3.80 | ₹0.63 | ₹-0.37 | ₹1.32 | ₹-6.41 | ₹1.77 | ₹-1.40 | ₹-3.09 | ₹0.34 | ₹3.99 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 205 Cr | 181 Cr | 272 Cr | 331 Cr | 327 Cr | 334 Cr | 311 Cr | Sign in for TTM |
| Operating expenses (approx.) | 149 Cr | 158 Cr | 215 Cr | 221 Cr | 273 Cr | 291 Cr | 284 Cr | Sign in for TTM |
| EBITDA | 55 Cr | 23 Cr | 57 Cr | 110 Cr | 54 Cr | 44 Cr | 27 Cr | Sign in for TTM |
| OPM % | 26.9% | 12.9% | 20.9% | 33.3% | 16.5% | 13.1% | 8.8% | Sign in for TTM |
| Other income | 3 Cr | 1 Cr | 6 Cr | 6 Cr | 9 Cr | 7 Cr | 9 Cr | Sign in for TTM |
| Interest | 3 Cr | 2 Cr | 1 Cr | 0.24 Cr | 0.94 Cr | 5 Cr | 8 Cr | Sign in for TTM |
| Depreciation | 25 Cr | 20 Cr | 22 Cr | 23 Cr | 22 Cr | 36 Cr | 28 Cr | Sign in for TTM |
| Profit before tax | 27 Cr | 2 Cr | 39 Cr | 89 Cr | 39 Cr | -0.31 Cr | -0.20 Cr | Sign in for TTM |
| Tax % | 4.7% | 501.4% | 26.5% | 27.8% | 32.8% | -2172.5% | -1613.3% | Sign in for TTM |
| Net profit | 25 Cr | -8 Cr | 29 Cr | 65 Cr | 26 Cr | -7 Cr | -3 Cr | Sign in for TTM |
| EPS (₹) | ₹18.27 | ₹-5.81 | ₹20.36 | ₹45.61 | ₹18.53 | ₹-4.86 | ₹-2.38 | Sign in for TTM |
| Dividend payout % | — | — | 0.1% | 2.7% | 0.0% | — | — | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity capital | 14 Cr | 14 Cr | 14 Cr | 14 Cr | 14 Cr | 14 Cr | 14 Cr |
| Reserves | 262 Cr | 253 Cr | 284 Cr | 347 Cr | 373 Cr | 366 Cr | 361 Cr |
| Borrowings | — | — | — | 0.0063 Cr | 18 Cr | 83 Cr | 123 Cr |
| Other liabilities | 73 Cr | 68 Cr | 54 Cr | 51 Cr | 95 Cr | 59 Cr | 78 Cr |
| Total liabilities | 348 Cr | 335 Cr | 352 Cr | 412 Cr | 500 Cr | 522 Cr | 577 Cr |
| Fixed assets (net) | — | — | — | 192 Cr | 232 Cr | 303 Cr | 386 Cr |
| CWIP | — | — | — | 31 Cr | 74 Cr | 36 Cr | 31 Cr |
| Investments | — | — | — | 68 Cr | 6 Cr | 16 Cr | 14 Cr |
| Inventories | — | — | — | 17 Cr | 16 Cr | 27 Cr | 26 Cr |
| Trade receivables | — | — | — | 22 Cr | 21 Cr | 21 Cr | 24 Cr |
| Cash & bank | — | — | — | 0.98 Cr | 2 Cr | 5 Cr | 0.08 Cr |
| Other assets | 348 Cr | 335 Cr | 352 Cr | 81 Cr | 148 Cr | 114 Cr | 96 Cr |
| Total assets | 348 Cr | 335 Cr | 352 Cr | 412 Cr | 500 Cr | 522 Cr | 577 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | — | 55 Cr | 93 Cr | 126 Cr | 40 Cr | 38 Cr |
| Cash from investing | — | — | -21 Cr | -48 Cr | -110 Cr | -86 Cr | -81 Cr |
| Cash from financing | — | — | -25 Cr | -9 Cr | 16 Cr | 59 Cr | 31 Cr |
| Net cash flow | — | — | 9 Cr | 36 Cr | 33 Cr | 13 Cr | -12 Cr |
| Free cash flow (OCF − Capex) | — | — | 55 Cr | 35 Cr | 126 Cr | -73 Cr | -53 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| ROCE % | 10.8% | 1.7% | 13.5% | 24.8% | 9.9% | 1.0% | 1.5% |
| ROE % | 0.0% | 0.0% | 9.6% | 17.9% | 6.8% | -1.8% | -0.9% |
| Debtor days | — | — | — | 24 | 24 | 23 | 28 |
| Inventory days | — | — | — | 127 | 79 | 97 | 99 |
| Days payable | — | — | — | 208 | 135 | 115 | 120 |
| Cash conversion cycle | — | — | — | -57 | -32 | 5 | 8 |
| Debt / equity | 0.00 | 0.00 | 0.00 | 0.0000 | 0.05 | 0.22 | 0.33 |
| Current ratio | — | — | — | 2.60 | 1.04 | 1.33 | 0.80 |
| Net debt / EBITDA | 0.00 | 0.00 | 0.00 | -0.0088 | 0.29 | 1.78 | 4.51 |
Compare with peers
Loading peers…